Ro
The National Institute on Aging will utilize Ro's telehealth platform to screen and recruit patients at elevated risk for developing Alzheimer's disease or other related dementia.
In February, Ro announced a $150 million fundraise that bumped its valuation to $7 billion.
The deal comes less than a year after the direct-to-consumer virtual care company scooped up Modern Fertility.
Also: Complex-care-management platform Memora Health and digital-fitness startup FitOn both raised $40 million.
This comes roughly two years after Ro inked a deal with Plenity creator Gelesis.
According to reporting by TechCrunch, employee morale is low as the company struggles to expand successfully beyond its men’s health products.
The platform, called Ro Mind, lets users fill out an assessment and then consult with a clinician.
The new acquistiion is expected to help the company grow out its diagnostic capabilities.
Ro will now be able to integrate Modern Fertility's hormone testing and other offerings into its platform.
Investors have showered the New York company with $876 million to date.